Page 29 - Live-cellanalysis handbook

Kinetic Proliferation Assays

References

1. Straussman R. et al.: Tumour micro-environment elicits innate 10. Cabrita, MA. Focal adhesion kinase inhibitors are potent anti-
resistance to RAF inhibitors through HGF secretion. Nature 2012, 487 angiogenic agents. Molec. Oncology 2001, 5(6):517-526.
(7408):500-504.
11. Janjetovic, K. Metformin reduces cisplatin-mediated apoptotic
2. Konecny GE, et al. Activity of the dual kinase inhibitor lapatinib death of cancer cells through AMPK-independent activation of
(GW572016) against HER-2-overexpressing and trastusumab- Akt. Europ. J. Pharmacol. 2011, 651(1-3):41-50.
treated breast cancer cells. Cancer Res 2006, 66(3):1630-1639.
12. Shao, J et al. AMP-activated protein kinase (AMPK) activation is
3. Sappal, DS, et al. Biological characterization of MLN944: A potent involved in chrysin-induced growth inhibition and apoptosis in
DNA binding agent. Molec. Cancer Ther. 2004, 3(1):47. cultured A549 lung cancer cells. Biochem. BioPhys. Res. Comm. 2012,
423(3):448-453.
4. Seynaeve, CM. et al. Differential inhibition of protein kinase C
isozymes by UCN-01, a staurosporine analogue. Mol. Pharmacol. 13. Ahmed, FE. Toxicology and human health effects following
1994, 45(6):1207-1214. exposure to oxygenated or reformulated gasoline. Tox. Letters 2001,
123(2-3):89-113.
5. Palom, Y. et al. Bioreductive metabolism of mitomycin C in EMT6
mouse mammary tumor cells: cytotoxic and non-cytotoxic 14. Boldingh Debernard, KA. Cell death induced by novel procaspase-3
pathways, leading to different types of DNA adducts. The effect activators can be reduced by growth factors. Biochem. Biophys. Res.
of dicumaro. Biochem. Pharamcol. 2001, 61(12):1517-1529. Comm. 2011, 413(2):364-369.
6. Chang, TC et al. Effects of transcription and translation inhbitors 15. Garcia-Martinez, JM. Ku-0063794 is a specific inhibitor of
on a human gastric carcinoma line. Potential role of Bcl-X(S) in the mammalian target of rapamycin (mTOR). Biochem. J. 2009,
apoptosis triggered by these inhibitors. Biochem. Pharmacol. 1997, 421(1):29-42.
53(7)96-977.
16. Strittmatter, F et al. Activation of protein kinase B/Akt by alpha1-
7. Roh, JL et al. The p53-reactivating small-molecule RITA enhances adrenoceptors in the human prostate. Life Sciences 2012, 90(11-
cisplatin-induced cytotoxicity and apoptosis in head and neck 12):446-453.
cancer. Cancer Let. 2012, 325(1):35-41.
17. Ballou, LM et al. Inhibition of Mammalian Target of Rapamycin
8. Aravena, C et al. Potential Role of Sodium-Proton Exchangers in Signaling by 2-(Morpholin-1-yl)pyrimido[2,1-a]isoquinolin-4-one.
the Low Concentration Arsenic Trioxide-Increased Intracellular pH J. Biol. Chem. 2007, 282(33):24463-70.
and Cell Proliferation. PLoS One 2012, 7(12): e51451.

9. Hu, W. The anticancer drug cisplatin can cross-link the
interdomain zinc site on human albumin. Chem. Commun. 2011,
47(21):6006-6008.

Representative IncuCyte Publications

1. Balaban S, et al. Adipocyte lipolysis links obesity to breast cancer 6. Lau J1-, et al. Tumour and host cell PD-L1 is required to mediate
growth: adipocyte-derived fatty acids drive breast cancer cell suppression of anti-tumour immunity in mice. Nat Commun. 2017
proliferation and migration. Cancer Metab, 2017, Jan 5:1. Feb 21;8:14572.

2. Blom M, et al. The atypical Rho GTPase RhoD is a regulator of actin 7. McDonald AI, et al. Endothelial regeneration of large vessels is a
cytoskeleton dynamics and directed cell migration. Exp Cell Res. biphasic process driven by local cells with distinct proliferative
2017,Mar 15;352(2):255-264. capacities. Cell Stem Cell. 2018 Aug 2;23(2):210-225.

3. Blum W, et al. Stem cell factor-based Identification and functional 8. Takigawa H, et al, Mesenchymal stem cells induce epithelial to
properties of in vitro-selected subpopulations of malignant mesenchymal transition in colon cancer cells through direct cell-
mesothelioma cells. Stem Cell Reports. 2017 Apr 11;8(4):1005-1017. to-cell Contact. Neoplasia. 2017 May;19(5):429-438.
4. Bussian TJ, et al. Clearance of senescent glial cells prevents 9. Zaretsky JM, et al. Mutations associated with acquired resistance
tau-dependent pathology and cognitive decline. Nature. 2018 to PD-1 blockade in melanoma. N Engl J Med. 2016 Sep
Oct;562(7728):578-582. 1;375(9):819-29.
5. Ihry RJ, et al. p53 inhibits CRISPR-Cas9 engineering in human
pluripotent stem cells. Nat Med., 2018, Jul; 24(7):939-946.

27